ES2055132T3 - Polipeptidos recombinantes del virus de la septicemia hemorragica de los peces. - Google Patents

Polipeptidos recombinantes del virus de la septicemia hemorragica de los peces.

Info

Publication number
ES2055132T3
ES2055132T3 ES89402812T ES89402812T ES2055132T3 ES 2055132 T3 ES2055132 T3 ES 2055132T3 ES 89402812 T ES89402812 T ES 89402812T ES 89402812 T ES89402812 T ES 89402812T ES 2055132 T3 ES2055132 T3 ES 2055132T3
Authority
ES
Spain
Prior art keywords
hemorrhageal
septicemia
viruses
female
recombinant polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89402812T
Other languages
English (en)
Inventor
Andre Renard
Michel Thiry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaneka Eurogentec SA
Original Assignee
Eurogentec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurogentec SA filed Critical Eurogentec SA
Application granted granted Critical
Publication of ES2055132T3 publication Critical patent/ES2055132T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)

Abstract

LA INVENCION TIENE POR OBJETO NUEVAS SECUENCIAS DE AMINOACIDOS QUE CONTIENEN ESPECIALMENTE TODO O PARTE DEL ENCADENAMIENTO DE AMINOACIDOS REPRESENTADO EN LAS FIGURAS III Y III CONTINUACION. ESTAS SECUENCIAS DE AMINOACIDOS SE PUEDEN USAR COMO PRINCIPIO ACTIVO DE VACUNA CONTRA LA SEPTICEMIA HEMORRAGICA VIRAL DE LOS PECES.
ES89402812T 1988-10-12 1989-10-11 Polipeptidos recombinantes del virus de la septicemia hemorragica de los peces. Expired - Lifetime ES2055132T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88402587 1988-10-12

Publications (1)

Publication Number Publication Date
ES2055132T3 true ES2055132T3 (es) 1994-08-16

Family

ID=8200430

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89402812T Expired - Lifetime ES2055132T3 (es) 1988-10-12 1989-10-11 Polipeptidos recombinantes del virus de la septicemia hemorragica de los peces.

Country Status (11)

Country Link
EP (1) EP0377349B1 (es)
JP (1) JPH04502902A (es)
AT (1) ATE106944T1 (es)
AU (1) AU4426689A (es)
CA (1) CA2000570A1 (es)
DE (1) DE68915988T2 (es)
DK (1) DK64691A (es)
ES (1) ES2055132T3 (es)
IS (1) IS3511A7 (es)
NZ (1) NZ230996A (es)
WO (1) WO1990004028A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2132961A1 (en) * 1992-03-27 1993-10-14 International Flower Developments Pty. Ltd. Genetic sequences encoding flavonoid pathway enzymes and uses therefor
EP2322656A1 (en) * 2009-11-17 2011-05-18 Centre National de la Recherche Scientifique (C.N.R.S) Methods for diagnosing skin diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492841B1 (fr) * 1980-10-23 1983-07-22 Agronomique Inst Nat Rech Virus mutant de septicemie hemorragique virale, vaccin contenant ce mutant et procede pour sa preparation

Also Published As

Publication number Publication date
DE68915988D1 (de) 1994-07-14
EP0377349B1 (fr) 1994-06-08
NZ230996A (en) 1991-09-25
IS3511A7 (is) 1990-04-13
DE68915988T2 (de) 1994-09-29
DK64691A (da) 1991-06-12
EP0377349A1 (fr) 1990-07-11
CA2000570A1 (fr) 1990-04-12
JPH04502902A (ja) 1992-05-28
ATE106944T1 (de) 1994-06-15
DK64691D0 (da) 1991-04-11
WO1990004028A1 (fr) 1990-04-19
AU4426689A (en) 1990-05-01

Similar Documents

Publication Publication Date Title
DE3278344D1 (en) Stabilization of influenza virus vaccine
PT83434B (pt) Processo de preparacao de virus recombinantes, de peptidos ou proteinas e de vacinas contra o sindroma de imunodeficiencia adquirida
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
ES2124532T3 (es) Sistema vector-huesped utilizable en terapia genica.
DK0677114T3 (da) Rekombinant svinekoppevirus
DK0561890T3 (da) DNA ekspressionssystemer baseret på alphavira
DK184186A (da) Terapeutisk praeparat til behandling af virussygdomme
PT670899E (pt) Proteinas de choque termico e tratamento de tumores
ES2144394T3 (es) Polipeptidos y peptidos recombinantes, acidos nucleicos que los codifican y utilizacion de dichos polipeptidos y peptidos para el diagnostico de la tuberculosis.
ES2163394T3 (es) Regiones serorreactivas situadas en las proteinas e1 y e2 de hpv16.
MX9700676A (es) Identificacion de la region de un gen citomegalovirus humano implicada en la desregulacion de la expresion de la cadena pesada del mhc de la clase i.
ES2145000T3 (es) Virus recombinante del avipox.
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
ES2055132T3 (es) Polipeptidos recombinantes del virus de la septicemia hemorragica de los peces.
ES2058100T3 (es) Vacuna combinada.
ES8800358A1 (es) Un procedimiento para preparar un polipeptido hibrido.
ES2118242T3 (es) Vacunas anti virus de la inmunodeficiencia felina (fiv).
ES2063897T5 (es) Vacuna contra el virus del colera porcino y diagnostico.
ES2149791T3 (es) Procedimiento para la inactivacion de virus en preparaciones de proteinas.
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
ES8504248A1 (es) Procedimiento para la fabricacion de un plasmido recombinante que contiene un aminoacido
DK0717048T3 (da) Cyclohexapeptider og deres blandinger, fremgangsmåde til fremstilling deraf samt deres anvendelse
AR248047A1 (es) Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 377349

Country of ref document: ES